Danaher Corporation (LON:0R2B)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 121.01B |
| Revenue (ttm) | 18.10B |
| Net Income (ttm) | 2.61B |
| Shares Out | n/a |
| EPS (ttm) | 3.63 |
| PE Ratio | 46.33 |
| Forward PE | 27.82 |
| Dividend | 0.69 (0.30%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 2,439 |
| Average Volume | 3,754 |
| Open | 229.61 |
| Previous Close | 226.00 |
| Day's Range | 226.51 - 229.61 |
| 52-Week Range | 171.02 - 258.01 |
| Beta | 0.93 |
| RSI | 62.38 |
| Earnings Date | Jan 28, 2026 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial numbers in USD Financial StatementsNews
Insider Sell: Teri List Sells 3,298 Shares of Danaher Corp (DHR)
Insider Sell: Teri List Sells 3,298 Shares of Danaher Corp (DHR)
3 More Good Stocks to Invest In After Earnings
These cheap stocks from wide-moat companies look attractive today.
Decoding Danaher's Options Activity: What's the Big Picture?
Financial giants have made a conspicuous bearish move on Danaher. Our analysis of options history for Danaher (NYSE: DHR) revealed 14 unusual trades. Delving into the details, we found 28% of traders...
Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript
Danaher Corporation (DHR) Jefferies London Healthcare Conference 2025 November 18, 2025 6:00 AM ESTCompany ParticipantsRainer Blair - President, CEO &...
Insider Action: Executives unload millions in major stock sales
CNBC’s Frank Holland reports major insider sales at Robinhood, Danaher, Hyatt and Minerals Therapeutics, all confirmed by SEC filings.
The Big 3: TMO, DHR, VLO
As A.I. stocks take a beating on Wednesday's trading session, Dan Deming offers his thoughts and example options trades in healthcare and energy stocks. He explains his bullish theses behind Thermo Fi...
SOLV vs. DHR: Which Stock Is the Better Value Option?
SOLV vs. DHR: Which Stock Is the Better Value Option?
2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon
A biotech upstart and a life sciences giant could be compelling additions to an investor's portfolio. NovoCure is a high-risk but potentially high-reward bet on industry-changing technology.
Danaher to Present at Jefferies Global Healthcare Conference
WASHINGTON , Nov. 11, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Jefferies Global Healthcare ...
SOLV or DHR: Which Is the Better Value Stock Right Now?
SOLV vs. DHR: Which Stock Is the Better Value Option?
Danaher stock may be turning the corner. What needs to happen to keep it that way
Danaher's rebound is generating optimism, but there's still work ahead for the company to hit is 2026 growth targets.
Top 15 High-Growth Dividend Stocks For November 2025
The Top 15 High-Growth Dividend Stock list for November 2025 offers a 1.39% yield and 19.88% five-year dividend growth. Despite underperforming SPY and VIG in October, the watchlist targets a long-ter...
DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE...
Is the Market Bullish or Bearish on Danaher Corp?
Danaher Corp's (NYSE: DHR) short interest as a percent of float has fallen 5.93% since its last report. According to exchange reported data, there are now 7.98 million shares sold short , which is 1....
The Richest 0.1% Are Buying These 3 Dividend Stocks Right Now
When ultra-rich investors start coalescing into the same names or put an unusually large amount of money into a single stock, that should raise more interest. That’s exactly what we’re seeing with Uni...
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Oct. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co...
DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher ...
Martin Zweig Detailed Fundamental Analysis - DHR
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin Zwei...
Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Danaher Corporation (NYSE: DHR) breached their fiduciary duties to ...
DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher ...
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Danaher (NYSE: DHR) has outperformed the market over the past 10 years by 1.03% on an annualized basis producing an average annual return of 13.48%. Currently, Danaher has a market capitalization of ...
These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings
Danaher Corporation (NYSE: DHR) reported better-than-expected third-quarter financial results on Tuesday . Danaher announced third-quarter adjusted earnings of $1.89 per share, which beat the analyst...
These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings
Danaher Corporation (NYSE:DHR) reported better-than-expected third-quarter financial results on Tuesday.
TD Cowen Raises Price Target for Danaher (DHR) to $260, Maintains Buy Rating | DHR Stock News
TD Cowen Raises Price Target for Danaher (DHR) to $260, Maintains Buy Rating | DHR Stock News
DHR Factor-Based Stock Analysis - Martin Zweig
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin Zwei...